Capillary Technologies India Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Clarification regarding exercise price'.
CAPILLARY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Capillary Technologies has issued a clarification to address feedback from Proxy Advisors regarding the exercise price of options under its ESOP 2021 scheme. The Postal Ballot Notice dated February 6, 2026 seeks shareholder approval to extend ESOP benefits to employees of subsidiary companies in India and overseas. The company clarified that all grants under ESOP 2021 will be priced by the Nomination and Remuneration Committee, with a maximum discount of 20% to the 90-day Volume Weighted Average Price (VWAP) preceding the grant date, computed on the stock exchange with the highest trading volume. The company emphasised that the pricing mechanism is objective, market-linked, and transparent, and follows the Companies Act, 2013 and SEBI SBEB Regulations, 2021.
This is a governance clarification and does not change the substance of the original resolution. It provides additional transparency on ESOP pricing, which may help secure shareholder approval in the postal ballot. Existing shareholders should be aware of potential dilution from ESOP grants to subsidiary employees, though the 20% discount cap on VWAP-based pricing limits downside.